EcoDrugPlus

Progesterone Receptor

Ensembl ID : ENSCAFG00020011021
Gene Symbol: PGR
3 Cross references
194 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSCAFG00020018888
Gene Symbol: PTGDR
3 Cross references
118 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCAFG00020012562
Gene Symbol: PTGDR2
3 Cross references
205 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSCAFG00020007434
Gene Symbol: PTGER1
3 Cross references
237 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSCAFG00020018884
Gene Symbol: PTGER2
3 Cross references
244 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCAFG00020017158
Gene Symbol: PTGER3
3 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSCAFG00020012207
Gene Symbol: PTGER4
3 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSCAFG00020015211
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSCAFG00020001637
Gene Symbol: PTGIR
3 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSCAFG00020015185
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSCAFG00020016543
Gene Symbol: PTGS2
3 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSCAFG00020023566
Gene Symbol: PSMA2
3 Cross references
182 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).